As of Oct 26, 2026: Robin Shane Readnour (Director, ANTX) reported 4 sales for $317K in the last 12 months (Form 4). ANTX's Quality Score is -2. Scores as of 10:16 PM ET, 15 minutes behind.

Robin Shane Readnour

Director of AN2 Therapeutics

4 stock trades in the last 12 months, shares they bought or sold themselves (not grants or options).

Bought$012 months Sold$317K12 months Last filedSep 11a planned sale

From SEC Form 4s · Insiders have 2 business days to file a trade

Every trade Robin Shane Readnour reported

Every sale was under a trading plan set up in advance. All 4 were held indirectly, as filed (through a trust, a fund, or another account).

Newest first, as filed

Stock	Trade	Amount	Trade	Shares	Traded Filed
ANTXAN2 TherapeuticsIndirect	SellPlan	$7Kat $6.02	SellPlan$7Kat $6.02	1,108 at $6.02Held indirectly, as filed	Sep 9filed Sep 11Sep 11SEC filing
ANTXAN2 TherapeuticsIndirect	SellPlan	$60Kat $6.02	SellPlan$60Kat $6.02	10,019 at $6.02Held indirectly, as filed	Sep 8filed Sep 8Sep 8SEC filing
ANTXAN2 TherapeuticsIndirect	SellPlan	$37Kat $6.07	SellPlan$37Kat $6.07	6,100 at $6.07Held indirectly, as filed	Sep 3filed Sep 8Sep 8SEC filing

1 more trade, the shares held after each, and every filing, for Pro members. See them free →

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 4 tradesSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Robin Shane Readnour's companies

Where they file, with the stock's Quality Score

Company	Title, as filed	Trades	Quality Score
ANTXAN2 TherapeuticsDirector	Directorfiled Sep 11	4	-2

Alerts for Robin Shane Readnour

One alert for each Form 4 they file.

Set an alert

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Here is what Pro members see.

Insider trades, sorted your way
Every CEO's buy is here, the biggest names first. Filter by role, side, and size, and set optional alerts.
Their trades on the chart
Insider buys and sales marked on the stock's chart, from a year to the full history.
Why a stock ranks
Its Quality Score, its rank, and the reasons behind it, on one card.
Congress trades
A member's trades, newest first, each with its amount. Sort and filter the whole list.
The score, added up
Price action, the company, and signals, each with its points, summed into one number on every stock's page.
14 chart checks, read for you
The ones firing on the stock, each in plain words, its rule a tap away.
Earnings, week by week
Who reports each day, and how each stock took its last four reports.
FDA dates, counted down
Each date in the company's words, its cash against the date, and an optional alert before it.
The market map
Every stock a box, colored by its Quality Score.
Themes, ranked live
Each theme's stocks ranked by Quality Score, live. Here, AI chips.
The top 10, every day
The ten highest Quality Scores at each close, kept day by day, week by week.
Optional alerts, your way
Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.
Your watchlist, scored
Your stocks by Quality Score, today's move, or name.
On your phone and your laptop
The same account and watchlist on both, each laid out for its screen.

Prices refresh every 2.5 seconds during market hours.
Optional alerts by push, email, or the bell.
Add it to your Home Screen and it opens like an app.

Others who file at AN2 Therapeutics

Insider trades by person